LABROSSE NICOLE (SVP, Chief Financial Officer) exercised options at HALOZYME THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
Common Stock
Shares
+5.09K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−2.75K
Price / share
$79.44
Trade value
$218.22K
% of position
Common Stock
Shares
+5.33K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−2.87K
Price / share
$79.44
Trade value
$228.31K
% of position
Common Stock
Shares
+13.35K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−7.27K
Price / share
$79.44
Trade value
$577.77K
% of position
Net shares
+10.88K
Net value
-$1.02M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/16/2026 | M · Option Exercise | +5.09K | — | — | 23.1% | 22.08K | 27.17K |
| Common Stock Direct | 2/16/2026 | F · Tax Withholding | −2.75K | $79.44 | $218.22K | 10.1% | 27.17K | 24.43K |
| Common Stock Direct | 2/16/2026 | M · Option Exercise | +5.33K | — | — | 21.8% | 24.43K | 29.75K |
| Common Stock Direct | 2/16/2026 | F · Tax Withholding | −2.87K | $79.44 | $228.31K | 9.7% | 29.75K | 26.88K |
| Common Stock Direct | 2/16/2026 | M · Option Exercise | +13.35K | — | — | 49.7% | 26.88K | 40.23K |
| Common Stock Direct | 2/16/2026 | F · Tax Withholding | −7.27K | $79.44 | $577.77K | 18.1% | 40.23K | 32.96K |
| Total | +10.88K | -$1.02M | ||||||
Restricted Stock Units
Common Stock
5.09K shares
Shares
−5.09K
Strike price
0
Held after
0.00
Exercisable
—
Restricted Stock Units
Common Stock
5.33K shares
Shares
−5.33K
Strike price
0
Held after
5.33K
Exercisable
—
Performance Stock Units
Common Stock
13.35K shares
Shares
−13.35K
Strike price
0
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock5.09K shares | 2/16/2026 | M · Option Exercise | −5.09K | 0 | — | 0.00 |
| Restricted Stock Units Direct | Common Stock5.33K shares | 2/16/2026 | M · Option Exercise | −5.33K | 0 | — | 5.33K |
| Performance Stock Units Direct | Common Stock13.35K shares | 2/16/2026 | M · Option Exercise | −13.35K | 0 | — | 0.00 |